Nitrogen

Description

Nitrogen, compressed, is identified by the CAS number 7727-37-9. It is a non-flammable gas.

Uses and Indications

This drug is indicated for use in specific medical situations where the administration of Nitrogen is deemed necessary. It is essential that this drug be administered only by or under the supervision of a licensed practitioner who possesses expertise in the use and administration of Nitrogen. The practitioner must be knowledgeable about the indications, effects, dosages, methods, frequency, duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

Limitations of use include the potential hazards associated with Nitrogen administration, which may render it contraindicated in certain circumstances. There are no specific teratogenic or nonteratogenic effects reported for this drug.

Dosage and Administration

Administration of Nitrogen is to be conducted only by or under the supervision of a licensed practitioner experienced in its use. It is essential that the practitioner is familiar with the indications, effects, dosages, methods, and frequency and duration of administration, as the use of Nitrogen may pose hazards or be contraindicated.

Nitrogen is administered via the respiratory route through inhalation. The active ingredient concentration is 990 mL of Nitrogen in a 1 L container. Practitioners should ensure that the administration technique is appropriate and that the patient is monitored for any adverse effects during and after the inhalation process.

Contraindications

Use of this product is contraindicated in situations where contact with eyes, skin, or clothing may occur, as exposure could lead to irritation or adverse reactions. Additionally, the product should not be dropped, as this may compromise its integrity and effectiveness.

Warnings and Precautions

Administration of Nitrogen may pose significant risks and is contraindicated in certain situations. It is imperative that this substance be used solely by or under the supervision of a licensed practitioner who possesses experience in the use and administration of Nitrogen. This practitioner should be well-versed in the indications, effects, dosages, methods, frequency, duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

Warnings

The use of Nitrogen involves exposure to high-pressure gas, which can lead to rapid suffocation. Additionally, the liquid and gas are extremely cold and under pressure, presenting a risk of severe frostbite and rapid suffocation.

General Precautions

To ensure safe handling and use of Nitrogen, the following precautions must be observed:

• Store and utilize Nitrogen in areas with adequate ventilation to prevent the accumulation of gas.

• Employ equipment that is rated for the cylinder pressure to avoid equipment failure.

• Install a backflow preventive device in the piping to mitigate the risk of contamination.

• Monitor the cylinder temperature, ensuring it does not exceed 52° C (125°F).

• Always close the valve after each use and when the cylinder is empty to prevent accidental release.

• Avoid contact with liquid Nitrogen; do not allow it to come into contact with eyes, skin, or clothing.

• When withdrawing liquid Nitrogen, it is essential to wear a face shield and gloves to protect against splashes.

• Handle cylinders with care; do not drop them. Utilize a suitable hand truck for the movement of containers.

• Follow the guidelines outlined in the Material Safety Data Sheet (MSDS) for safe handling and emergency procedures.

Emergency Medical Help Instructions

In the event of inhalation, it is critical to remove the affected individual to fresh air immediately. If the individual is not breathing, artificial respiration should be administered. If breathing difficulties arise, oxygen should be provided, and a physician should be contacted without delay. In cases of frostbite, prompt medical treatment is essential.

No specific laboratory tests are recommended for the monitoring of Nitrogen use. However, practitioners should remain vigilant and prepared to respond to any adverse effects or emergencies that may arise during administration.

Side Effects

Patients should be aware of the potential adverse reactions associated with exposure to extremely cold liquid and gas under pressure. These conditions can lead to serious health risks, including rapid suffocation and severe frostbite.

In the event of inhalation, it is crucial to remove the affected individual to fresh air immediately. If the individual is not breathing, artificial respiration should be administered, and if breathing difficulties arise, supplemental oxygen should be provided. It is imperative to seek medical attention promptly.

In cases of frostbite, immediate medical treatment is essential to mitigate the effects and prevent further complications.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there are no known interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are necessary at this time.

Packaging & NDC

The table below lists all NDC Code configurations of Nitrogen, the U.S. brand-name prescription product. Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

There is no specific pediatric use information available for this medication, including recommended ages, dosing differences, safety concerns, or special precautions for children. Healthcare professionals should exercise caution when considering the use of this medication in pediatric patients due to the absence of relevant data.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

The administration of Nitrogen during pregnancy may pose potential risks and is contraindicated in certain situations. Pregnant patients should be closely monitored, and the use of Nitrogen should only occur under the supervision of a licensed practitioner experienced in its administration. This practitioner must be knowledgeable about the indications, effects, dosages, methods, frequency, duration of administration, and the associated hazards and contraindications.

Due to the lack of comprehensive studies on the effects of Nitrogen on fetal outcomes, healthcare professionals are advised to exercise caution when considering its use in pregnant patients. The potential for adverse effects necessitates a careful assessment of the risks versus benefits in this population. Women of childbearing potential should be informed of these considerations prior to administration.

Lactation

There is no specific information available regarding the use of this medication in nursing mothers or its effects during lactation. Healthcare professionals should consider the lack of data when advising lactating mothers about the use of this medication. The potential risks and benefits should be carefully weighed in the context of the individual patient's situation.

Renal Impairment

There is no specific information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution when prescribing to patients with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there is no information available regarding dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population.

Overdosage

There is currently no specific information available regarding overdosage for this medication. Healthcare professionals are advised to monitor patients closely for any unusual symptoms or adverse effects that may arise. In the event of suspected overdosage, it is recommended to initiate supportive care and symptomatic treatment as necessary.

Healthcare providers should consider contacting a poison control center or a medical toxicologist for guidance on management strategies tailored to the individual case. Continuous assessment of the patient's clinical status is essential to ensure appropriate interventions are implemented promptly.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data in these areas limits the understanding of the compound's potential effects in nonclinical settings.

Postmarketing Experience

No postmarketing experience details are available in the provided text.

Patient Counseling

Healthcare providers should advise patients that the administration of Nitrogen may pose hazards or be contraindicated. It is essential that Nitrogen is used only by or under the supervision of a licensed practitioner who is experienced in its use and administration. Patients should be informed that the practitioner must be familiar with the indications, effects, dosages, methods, frequency and duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

Providers must emphasize the warning regarding the high-pressure gas contained in Nitrogen, which can lead to rapid suffocation. Patients should be instructed to store and use Nitrogen in well-ventilated areas and to utilize equipment that is rated for cylinder pressure. It is critical to use a backflow preventive device in the piping and to ensure that the cylinder temperature does not exceed 52°C (125°F). Patients should be reminded to close the valve after each use and when the cylinder is empty, and to follow the guidelines outlined in the Material Safety Data Sheet (MSDS).

In the event of inhalation, healthcare providers should instruct patients to remove themselves to fresh air. If the patient is not breathing, they should be advised to perform artificial respiration, and if breathing is difficult, to provide oxygen. It is important to call a physician in such cases.

Patients should also be cautioned to always keep the container in an upright position and to avoid changing or forcing connections. The extremely cold nature of the liquid and gas under pressure can cause rapid suffocation and severe frostbite. Therefore, patients should be advised to store and use Nitrogen with adequate ventilation and to avoid contact with eyes, skin, or clothing. When withdrawing liquid, patients should wear a face shield and gloves, and should not drop the container. A suitable hand truck should be used for moving the container.

In case of frostbite, patients should be instructed to seek medical treatment immediately.

Storage and Handling

The product is supplied in a cylinder format, with specific handling and storage requirements to ensure safety and efficacy. It is essential to store and use the cylinder in an area with adequate ventilation. The temperature of the cylinder must not exceed 52° C (125°F) to maintain product integrity.

After each use and when the cylinder is empty, the valve should be closed to prevent any accidental release of contents. The container must always be kept in an upright position to avoid leaks and ensure safe handling. It is critical not to change or force fit connections, as this may compromise the integrity of the system.

For liquid withdrawal, appropriate personal protective equipment, including a face shield and gloves, should be worn to prevent exposure. Care must be taken to avoid contact with eyes, skin, or clothing, as the liquid can be hazardous. Additionally, the cylinder should not be dropped; a suitable hand truck should be utilized for the movement of the container.

All handling and usage should be conducted in accordance with the Material Safety Data Sheet (MSDS) to ensure compliance with safety protocols.

Additional Clinical Information

Patients should be aware that the route of administration for this product is via respiratory inhalation. It is crucial that administration is conducted only by or under the supervision of a licensed practitioner experienced in the use of Nitrogen, who understands the indications, effects, dosages, methods, and potential hazards associated with its use.

Clinicians must inform patients of the significant risks involved, including the potential for rapid suffocation and severe frostbite due to the extremely cold liquid and gas under pressure. Adequate ventilation is essential during storage and use, and precautions should be taken to prevent contact with eyes, skin, or clothing. In the event of inhalation, patients should be moved to fresh air, and if breathing is difficult, oxygen should be administered. Immediate medical attention is necessary for frostbite cases.

FDA Insert (PDF)

This document is the official FDA-approved prescribing information for Nitrogen as submitted by Quality Air Products Inc. It includes detailed information about indications, dosage, contraindications, warnings, and clinical pharmacology.

View full prescribing information (PDF)